Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism
Xiaoqing Huang, Qiongyun Chen, Yanyun Fan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114300-114300
Open Access | Times Cited: 25

Showing 25 citing articles:

The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 249
Prebiotics modulate the microbiota–gut–brain axis and ameliorate anxiety and depression-like behavior in HFD-fed mice
Igor Henrique Rodrigues de Paiva, Laís Macêdo Maciel, Rodrigo Soares da Silva, et al.
Food Research International (2024) Vol. 182, pp. 114153-114153
Closed Access | Times Cited: 19
Extraction, physicochemical properties, bioactivities and application of natural sweeteners: A review
Yanyu Sun, Jing Liang, Zhiruo Zhang, et al.
Food Chemistry (2024) Vol. 457, pp. 140103-140103
Closed Access | Times Cited: 12
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Yuezhi Zhu, Jen Kit Tan, Jia Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 329-329
Open Access | Times Cited: 11
Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora
Xingwen Yang, Shiwei Yao, Qihong Jiang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 14
Closed Access | Times Cited: 5
Gut microbiome and metabolome characteristics of patients with cholesterol gallstones suggest the preventive potential of prebiotics
Ye Liu, Hexin Li, Tieying Sun, et al.
iMeta (2025)
Open Access
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease
Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 2, pp. e2411002-e2411002
Closed Access
Polysaccharides Extracted from Old Stalks of Asparagus officinalis L. Improve Nonalcoholic Fatty Liver by Increasing the Gut Butyric Acid Content and Improving Gut Barrier Function
Wenlong Sun, Jinghan Jia, Guangpeng Liu, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Benefits of inulin and fructo-oligosaccharides on high fat diet-induced type 2 diabetes mellitus by regulating the gut microbiota in mice
Xiaoqin Ding, Qingyan Chen, Lanlan Du, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109908-109908
Closed Access
Dietary fiber mitigates the differential impact of beef and chicken meat consumption on rat intestinal health
Núria Elias Masiques, Jo De Vrieze, Lieselot Hemeryck, et al.
Food & Function (2025)
Open Access
Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation
Rodrigo Soares da Silva, Ingrid Prata Mendonça, Igor Henrique Rodrigues de Paiva, et al.
International Journal of Food Sciences and Nutrition (2023) Vol. 74, Iss. 7, pp. 760-780
Closed Access | Times Cited: 8
Gut Microbes, Diet, and Genetics as Drivers of Metabolic Liver Disease: A Narrative Review Outlining Implications for Precision Medicine
Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109704-109704
Closed Access | Times Cited: 3
Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases
Fernanda Raya Tonetti, Álvaro Eguileor, Cristina Llorente
eGastroenterology (2024) Vol. 2, Iss. 3, pp. e100098-e100098
Open Access | Times Cited: 3
Microbiome-based precision nutrition: Prebiotics, probiotics and postbiotics
Adrián Odriozola, Adriana González-Silvera, Iñaki Odriozola, et al.
Advances in genetics (2024), pp. 237-310
Closed Access | Times Cited: 2
Mechanisms of action and applications of Polygonatum sibiricum polysaccharide at the intestinal mucosa barrier: a review
Yu Ren, Yi Sun, Yu‐Ying Liao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Role of the Gut Microbiome in Metabolic dysfunction-Associated Steatotic Liver Disease
Salim Maher, Jayashi Rajapakse, Emad El‐Omar, et al.
Seminars in Liver Disease (2024)
Closed Access | Times Cited: 2
Effects of Different Types of Dietary Fibers on Lipid Metabolism and Bile Acids in Weaned Piglets
Yaolian Hu, Dongting He, Bing Yu, et al.
Animals (2023) Vol. 13, Iss. 20, pp. 3266-3266
Open Access | Times Cited: 4
The Current and Future State of Microbiome Therapeutics in Liver Disease
Patricia P. Bloom, Jasmohan S. Bajaj
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1S, pp. S36-S41
Open Access | Times Cited: 4
Fructooligosaccharides Supplementation: A Good Choice for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease?
Priscila Nogueira Bezan, Héric Holland, Bárbara Ferreira Vercesi, et al.
Applied Biosciences (2024) Vol. 3, Iss. 1, pp. 123-136
Open Access | Times Cited: 1
Heat-moisture and acid treatments can increase levels of resistant starch in arrowroot starch without adversely affecting its prebiotic activity in human colon microbiota
Hila Tarazi-Riess, Carmit Shani-Levi, Uri Lesmes
Food & Function (2024) Vol. 15, Iss. 11, pp. 5813-5824
Closed Access | Times Cited: 1
Fructooligosaccharides Supplementation: A Good Choice for Prevention and Treatment of Non-alcoholic Fatty Liver Disease?
Priscila Nogueira Bezan, Héric Holland, Bárbara Ferreira Vercesi, et al.
(2023)
Open Access | Times Cited: 1
Navigating the Gut-Brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy
Victory Aghogho Emojevwe, Arman Shahriari, Hamidreza Mahboobi
The International Journal of Gastroenterology and Hepatology Diseases (2024) Vol. 03
Closed Access
Influence of different types of dietary sugars on the intestinal mucosa and hepatic lipid metabolism in germ-free mice
Hee‐Kyoung Son, Hyunjhung Jhun, Hye‐Bin Lee, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150707-150707
Open Access
Nobiletin attenuates alcohol-related liver disease by inhibting gut-liver inflammation and gut microbiota disturbance in mice
Lalai Zikela, Huilin Zhu, Zhuoli Yu, et al.
European Journal of Nutrition (2024) Vol. 64, Iss. 1
Closed Access
Revolutionary Breakthroughs
Nahúm Méndez‐Sánchez, Mariana M. Ramírez-Mejía
(2024), pp. 115-124
Closed Access
Page 1

Scroll to top